The vascularity of colorectal liver metastases

European Journal of Surgical Oncology

Volumn 22, Issue 4, 1996, Pages 389-396

  Shankar, A ^a   Loizidou, M ^a   Taylor, I ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLORECTAL TUMOR; HUMAN; LIVER TUMOR; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REVIEW; VASCULARIZATION;

COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0030209934     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(96)90374-1     Document Type: Article

References (88)

1. Goligher J. Results of operations for large bowel cancer. In: Decosse JJ (ed.) Large Bowel Cancer. Churchill Livingstone, 1981.
2. Gill PG, Morris PJ. The survival of patients with colorectal cancer treated in a regional hospital. Br J Surg 1978; 65: 17-20.
3. Cedermark BJ, Blumenson LE, Pickren JW, et al. The significance of metastases in adenocarcinomas of the colon and rectum. Surg Gynecol Obstet 1977; 144: 537-46.
4. Scheele J, Stangl R, Altendorf-Hoffman A. Hepatic metastases from colorectal carcinoma; impact of surgical resection on the natural history, Br J Surg 1990; 77: 1241-6.
5. Chang AE, Schneider PD, Sugarbaker PH, Simpton C, Culmane M, Steinberg SM. A prospective randomised trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206: 685-93.
6. Martin JK, O'Connel MJ, Wieand HS, et al. Intra-arterial floxuridine versus systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 1990; 125: 1022-6.
7. Krylova NY Characteristics of microcirculation in experimental tumours. Biblio Anat 1969; 10: 301-3.
8. Ashraf S, Loizidou M, Crowe R, Turmaine M, Taylor I, Burnstock G. Blood vessels in liver metastases from both sarcoma and carcinoma lack perivascular innervation and smooth muscle cells. (In press.)
9. Effert PJ, Stromeyer TG. Theories on the metastatic process and possible therapeutic options. Urol Res 1995; 23: 11-9.
10. Murphy P, Alexander P, Senior PV. Mechanisms of organ selective tumour growth by blood borne cancer cells, Br J Cancer 1988; 57: 19-31.
11. Manishen W, Sivanathan K, Orr F. Resorbing bone stimulates tumour cell growth: a role for the host microenvironment in bone metastases. Am J Path 1986; 123: 39-45.
12. Orr F, Millar-Booth W, Singh G. Chemotactic activity of bone and platelet derived TGF-BETA for bone metastasising rat walker 256 carcinosarcoma cells. Invasion Metastases 1995; 10: 241-52.
13. Nicolson GL. Organ specificity of tumour metastases: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastases Rev 1988; 7: 143.
14. Steeg P. Invasion and metastasis. Curr Opin Oncol 1992; 4: 134-41.
15. Goldfarb R, Brunson K. Therapeutic agents for treatment of established metastases and inhibitors of metastatic spread; preclinical and clinical progress. Curr Opin Oncol 1992; 4: 1130-41.
16. Watson S, Morris T, Robinson G, Crimmin M, Brown P, Hardcastle J. Inhibition of matrix metalloproteinase inhibitor batimasat (BB-94) in two human colon carcinoma metastasis. Cancer Res 1995; 55: 3629-33.
17. Panis Y, Ribeiro J, Chreetien Y. Dormant liver metastases; an experimental study. Br J Surg 1992; 79: 221-3.
18. Loizidou MC, Lawrence R, Holt S, et al. Facilitation by partial hepatectomy of tumour growth within the rat liver following intra-portal injection of syngeneic tumour cells. Clin Exp Metastasis 1991; 9: 335-49.
19. Hughes K, Simon R, Songhorabodi S. Resection of the liver for colorectal carcinoma metastases; a multi-institutional study of patterns of recurrence. Surgery 1986; 100: 278-84.
20. Steele G, Ravikumar T. Resection of hepatic metastases from colorectal cancer: biologic perspectives. Ann Surg 1989; 210: 127-38.
21. Kawaguchi T, Nakamura K. Relationship between transcerebral passage of tumour cells and brain metastasis. Gann 1977; 68: 65-71.
22. Warren BA. The microinjury hypothesis and metastasis. In: Honn K, Sloane BF (eds) Haemostatic Mechanisms and Metastases. Marinus Nijhoff, 1980.
23. Slooter G, Marquet R, Jeekel J. Tumour growth stimulation after partial hepatectomy can be reduced by treatment with tumour necrosis factor alpha. Br J Surg 1995; 82: 129-32.
24. Orosz P, Kruger A, Hubbe M, et al. Promotion of experimental liver metastases by tumour necrosis factor. Im J Cancer 1985; 60: 867-71.
25. Haugeberg G, Strohmeyer T, Lierse W, Bocker W. The vascularisation of liver metastases. J Cancer Res Clin Oncol 1988; 114: 415-9.
26. Taylor I, Machin D, Mullee M, et al. A randomised controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg 1985; 72: 359-63.
27. Beart RW, Moertel CG, Wieand HS. Adjuvant therapy of resectable colorectal carcinoma with 5-fluorouracil administered by portal infusion. Arch Surg 1990; 125: 897-901.
28. Swiss Group for Chemical Cancer Research (SAKK). Long term results of a single course of adjuvant intraportal chemotherapy for colorectal cancer. Lancet 1995; 345: 349-53.
29. Wolmark N, Rockette H, Wickerman DL. Adjuvant therapy of Dukes A, B and C adenocarcinoma of the colon with portal vein fluorouracil hepatic infusion; preliminary results of national surgical adjuvant breast and bowel project protocol. c-02. J Clin Oncol 1990; 8: 1466-75.
30. Folkman J. What is the evidence that tumours are angiogenesis dependent. J Nat Cancer Inst 1990; 82: 4-6.
31. Paweletz N, Knierim. Tumour related angiogenesis. Crit Rev Oncol Haematol 1989; 9: 197-242.
32. Blood CH, Zetter BR. Tumour interaction with the vasculature: angiogenesis and tumour metastases. Biochem Biophys Acta 1990; 1032: 89-118.
33. Ingber D, Fujita T, Kishimoto S, Sudo K. Brem H, Folkman J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 1990; 348: 555-7.
34. Oikawa T, Hasegawa M, Shimamura M, Ashino H, Muroto S, Morita I. Eponemycin, a novel antibiotic is a highly powerful angiogenesis inhibitor. Biochem Biophys Res Commun 1991; 181: 1070-7.
35. Hawkins MJ. Clinical trials of antiangiogenic agents. Curr Opin Gastroenterol 1995; 7: 90-3.
36. Prehn R. The inhibition of tumour growth by tumour mass. Cancer Res 1991; 51: 2-4.
37. O'Reilly M, Holmgren L, Shing Y, et al. Angiostatin; a novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma. Cell 1994; 79: 1-20.
38. Koishi Y, Tanguchi H, Tanaka H, et al. Inhibition of liver metastases. Gan To Kagaku Ryoho 1994; 21: 2118-20.
39. Hiroyuki K, Tanaka T, Matsuda I, et al. Comparison of the inhibitory effect of the angiogenesis inhibitor TNP-470 and mitomycin on the growth of liver metastases of human colon cancer. Int J Cancer 1995; 61: 268-71.
40. Tanaka H, Taniguchi K, Mugitani T, et al. Intra-arterial administration of the angiogenesis inhibitor TNP-470 blocks where liver metastasis in a rabbit model. Br J Cancer 1995; 72: 650-3.
41. Warren RS, Yuan H, Malti MR, Gillett NA, Ferrara N. Regulation by vascular endothelial growth factor of human colon cancer tumourgenesis in a mouse model of experimental liver metastases. J Clin Invest 1995; 95: 1789-97.
42. Nott DM, Baxter J, Yates J, et al. Effect of a somatostatin analogue (SMS 201-995) on the growth and development of hepatic tumour derived by intraportal injection of Walker cells in the rat. Br J Surg 1989; 76: 1149-51.
43. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Path 1954; 30: 969-77.
44. Lien W, Ackerman N. The blood supply of experimental liver metastases II. A microcirculatory study of the normal and tumour vessels of the liver with the use of perfusion silicon rubber. Surgery 1970; 68: 334-40.
45. Lin G, Lunderquest A, Hagerstrand I, Boijsen E. Post mortem examination of the blood supply and vascular pattern of small liver metastases in man. Surgery 1984; 96: 517-26.
46. Archer SG, Gray SN. Vascularization of small liver metastases. Br J Surg 1989; 76: 545-8.
47. Gelin LE, Lewis DH, Nilsson L. Liver blood flow in man during abdominal surgery II. The effect of hepatic artery occlusion on the blood flow through metastatic tumour nodules. Acta Hepatosplenog 1968; 15: 21-4.
48. Taylor I, Bennett R, Sherriff S. The blood supply of colorectal liver metastases. Br J Cancer 1979; 39: 749-56.
49. Ridge JA, Bading JR, Gelbard AS, Benua RS, Daly JM. Perfusion of colorectal liver metastases; relative distribution of flow from the hepatic artery and portal vein. Cancer 1986; 59: 1547-53.
50. Jain RK. Barriers to drug delivery in solid tumours. Scient Am 1994; 271: 58-65.
51. Less JR, Posner MC. Boucher Y, Borochovitz D, Wolmark N, Jain RK. Interstitial hypertension in human breast and colorectal tumours. Cancer Res 1992; 52: 6731-4.
52. Long DM. Vasculature ultrastructure of human meningiomas and schwannomas. J Neurosurg 1973; 38: 409-19.
53. Ashraf S, Crowe R, Loizidou M, Turmaine M, Taylor I, Burnstock G. The absence of autonomic perivascular nerves in human colorectal liver metastases. (In press.)
54. Burnstock G. Integration of factors controlling vascular tone. Anaesthesiol 1993; 79: 1368-80.
55. Vallance P, Collier J, Moncada S. Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo. Cardiovasc Res 1989; 23: 1053-7.
56. Yanagisawa M, Kurihara H, Rimura S, et al. A novel vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-5.
57. Kushuhara M, Yamaguchi K, Nagasaki K, et at. Production of endothelium in human cancer cell lines. Cancer Res 1990; 50: 3257-61.
58. Andrade SP, Hart IR, Piper PJ. Inhibitors of nitric oxide synthase selectively reduce flow in tumour associated neovasculature. Br J Pharmacol 1992; 107: 1092-5.
59. Buttery LDK, Springhall DR, Andrade SP, Riveros-Moreno, Hart I, Piper PJ, Polak JM. Induction of nitric oxide synthase in the neovasculature of experimental tumours in mice. J Path 1993; 171: 311-9.
60. Kennovin GD, Flitney FW, Hirst DG. 'Upstream' modification of vasoconstrictor responses in rat epigastric artery supplying an implanted tumour. Adv Exp Med Bio 1994; 345: 411-6.
61. Sitzmann JV, Wu Y, Cameron J. Altered angiotensin II receptors in human hepatocellular and hepatic metastatic colon cancers. Ann Surg 1994; 219: 500-7.
62. Hemingway DM, Cooke TG, Grime SJ, Nott DM, Jenkins SA. Changes in hepatic haemodynamic and hepatic perfusion index during the growth and development of hypovascular HSN sarcoma in rats. Br J Surg 1991; 78: 326-30.
63. Nott DM, Grime SJ, Yates J, Baxter JN, Cooke TG, Jenkins SA. Changes in hepatic haemodynamics in rates with overt tumour. Br J Cancer 1991; 64: 1088-92.
64. Leveson SH, Wiggins PA, Nasiru TA, Giles GR, Robinson PA, Parkin A. Improved detection of hepatic metastases by the use of dynamic flow scintigraphy. Br J Cancer 1983; 47: 419.
65. Hemingway DM, Cooke TG, Grime SJ, Jenkins SA. Changes in liver blood flow associated with the growth of hepatic LV10 and MC28 sarcomas in rats. Br J Surg 1993; 80: 495-8.
66. Leen E, Goldberg J, Robertson J, Sutherland R, Hemingway D, Cooke T, McArdle C. Detection of hepatic metastases using duplex colour doppler sonography. Ann Surg 1991; 214: 599-604.
67. Leen E, Goldberg J, Robertson J, Angerson W, Sutherland G, Cooke T, McArdle C. Early detection of occult colorectal hepatic metastases using duplex colour doppler sonography. Br J Surg 1993; 80: 1249-51.
68. Leen E, Goldberg J, Robertson J, Sutherland G, McArdle C. The use of duplex sonography in the detection of colorectal hepatic metastases. Br J Cancer 1991; 63: 323-5.
69. Leen E, Angerson W, Wotherspoon H, Moule B, Cooke T, McArdle C. Detection of colorectal liver metastases; comparison of laparotomy, CT, US and doppler perfusion index and evaluation of post operative results. Radiol 1995; 195: 113-6.
70. Finlay I, McArdle C. Occult metastases in colorectal cancer. Br J Surg 1986; 73: 732-5.
71. Carter R, Anderson AJ, Cooke T, Baxter J, Angerson W. Splanchnic blood flow changes in the presence of hepatic tumour; evidence of a humoral mediator. Br J Cancer 1994; 69: 1025-6.
72. Warren H, Angerson W, Leen E, Carter R, McArdle C, Cooke T. Haemodynamic changes associated with colorectal liver metastases; evidence of a humoral mediator. Br J Surg 1993; 80: 1461.
73. Rubanyi GM, Polokoff MA. Endothelins, molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 1994; 46: 325-69.
74. Ackerman NB, Makohon S. The blood supply of experimental liver metastases VII; further studies on increased tumour vascularity caused by epinephrine. Microcirculation, Endothel Lymph 1984; 1: 547-68.
75. Ackerman NB, Hechmer PA. The blood flow of experimental liver metastases v increased tumour perfusion with epinephrine. Am J Surg 1980; 140: 625-31.
76. Ackerman N, Jacobs R, Bloom N, Poon T. Increased capillary flow in intrahepatic tumours due to alpha adrenanergic effects of catecholamines. Cancer 1988; 61: 1550-4.
77. Hafstrom L, Nobin A, Persson B, Sundquist K. Effects of catecholamines on cardiovascular response and blood flow distribution to normal tissue and liver tumours in rats. Cancer Res 1980; 40: 481-5.
78. Li Y, Li HC, Zhang LH. The effects of angiotensin 2 and other vasoactive agents on the blood flow in Yoshida ascites hepatoma. Chung Hua I Hsueh Tsa Chi Taipei 1993; 73: 23-5.
79. Burton MA, Gray BN. Redistribution of blood flow to experimental hepatic tumours with noradrenaline and propranolol. Br J Cancer 1987; 56: 585-8.
80. Sasaki Y, Imaoka S, Hasegawa Y, et al. Changes in distribution of hepatic blood flow is influenced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer 1985; 55: 311-6.
81. Hennigan T, Allen-Mersh T. Duration of blood flow reduction to normal liver tissue induced by angiotensin, vasopressin and endothelin. Eur J Surg Oncol 1994; 20: 446-8.
82. Hemingway DM, Angerson WJ, Anderson JH, Goldberg JA, McArdle CS, Cooke TG. Monitoring blood flow to colorectal liver metastases using laser doppler flowmetry: the effect of angiotensin II. Br J Cancer 1992; 66: 958-60.
83. Leen E. Angerson WJ, Warren HW, Goldberg JA, Sutherland GR, Cooke TG, McArdle CS. Duplex colour doppler sonography measurement of changes in hepatic arterial haemodynamics following intra-arterial angiotensin II infusion. Br J Cancer 1993; 67: 1381-4.
84. Dworkin MJ, Carnachan P, Allen Mersh TG. Vasoactive agents do not increase blood flow to liver but endothelin does produce a rise in tumour to liver blood flow ratio. Br J Surg (Abstract.) 1992; 79: 1240.
85. Dworkin M, Carnochan P, Allen-Mersh TG. Nitric oxide sustains vasopressin induced vasoconstriction. Br J Cancer 1995; 71: 942-4.
86. Goldberg JA, Kerr DJ, Wilmott N, McKillop JH, McArdle CS. Regional chemotherapy for colorectal metastases; a phase 2 evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases. Br J Surg 1990; 77: 1238-40.
87. Hemingway DM, Cooke T, Chang D, Grime SJ, Jenkins SA. The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour. Br J Cancer 1991; 63 495-8.
88. Bloom ND, Kroop E, Sadjadi M, Jacobs R, Ramaswany G, Ackerman NB. Enhancement of tumour blood flow and tumoricidal effect of doxorubicin by intraportal epinephrine in experimental liver metastases. Arch Surg 1987; 122: 1269-72.